medical-devices

United States Interventional Oncology Device Market Report 2016


Published On : Nov 2016

Category : In Vitro Diagnostics

No. of Pages : 103 pages

  • $3800
  • $7600

Please click below to avail discount on this report

This report studies sales (consumption) of Interventional Oncology Device in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Philips Volcano
Boston Scientific
GE Healthcare
Silicon Valley Medical Instruments
St. Jude Medical
Medtronic
Hitachi Aloka Medical America
Infraredx

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by applications, this report focuses on sales, market share and growth rate of  Interventional Oncology Device in each application, can be divided into
Application 1
Application 2
Application 3

In vitro diagnostic products, or medical apparatus, equipment, kits, and reagents being used usually in combination, are absolutely essential in figuring out invaluable data while monitoring patients during therapy. Recently, the overall industry of in vitro diagnostics has been experiencing changes, mostly due to the surge in demand for them from emerging economies. At the same time, developed economies continue on their high rates of research and development in the industry.

This research report on the United states interventional oncology device market report 2016 uses parallel comparisons between the past values of the market and its current standing, in order to formulate the scope of the market for the coming years. This is done using proven research methodologies that create a very accurate portrait of the market using the available facts. The report marks and explains all the key drivers, restraints, and the various trends that are currently an integral part of the market. The report also generates theories on the market as to where it is expected to be in the years to come. This involves forming predictions on market positions and values for the given forecast period, while also allowing readers to visualize their position in the market for this period. The report provides an exhaustive volume of data on the current state of the market and its comparison to the past data gathered from the archives, for the purpose of drawing simple conclusions that can be easily acted upon by market entities. Players in the United states interventional oncology device market report 2016 or even investors can find suitable areas of improvement and expansion through the research results provided in the report. Through the use of proven methodologies such as Porter’s Five Forces analysis and a company-oriented SWOT analysis, the report drives home the key features of the market that readers need to take away with them.

The report’s regional analysis of the United states interventional oncology device market report 2016 is beneficial for players of all sizes, due to the stepwise explanation and data presentation provided. What this means for the regional entities is a thorough elaboration on the factors that are affecting the market within their region of interest. They can thus use this data to formulate strategies that can further solidify their hold in the market for that region. Meanwhile, the globally prominent players or even the multi-region ones can create for themselves a successful plan for future expansion and consolidation. Whether a reader’s plan is to expand aggressively through mergers and acquisitions, or to consolidate their client pools in the regions they also work in, the report provides enough data to perform all strategies with relative ease.

The competitive landscape of the United states interventional oncology device market report 2016 is also explained within this report. It is one of the key sections that can be used by a reader to evaluate their standing in the market and find out what they can do to improve it. The report thus helps readers evaluate their business strategies and helping them strengthen their business propositions for the coming years. The aspect of business rivalries is a key matter in the market, and the report helps its readers gain an edge in the competition by presenting a compilation of the facts and figures on the leading players in the market today.

Table of Contents

United States Interventional Oncology Device Market Report 2016
1 Interventional Oncology Device Overview
1.1 Product Overview and Scope of Interventional Oncology Device
1.2 Classification of Interventional Oncology Device
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Interventional Oncology Device
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Interventional Oncology Device (2011-2021)
1.4.1 United States Interventional Oncology Device Sales and Growth Rate (2011-2021)
1.4.2 United States Interventional Oncology Device Revenue and Growth Rate (2011-2021)

2 United States Interventional Oncology Device Competition by Manufacturers
2.1 United States Interventional Oncology Device Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Interventional Oncology Device Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Interventional Oncology Device Average Price by Manufactures (2015 and 2016)
2.4 Interventional Oncology Device Market Competitive Situation and Trends
2.4.1 Interventional Oncology Device Market Concentration Rate
2.4.2 Interventional Oncology Device Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Interventional Oncology Device Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Interventional Oncology Device Sales and Market Share by Type (2011-2016)
3.2 United States Interventional Oncology Device Revenue and Market Share by Type (2011-2016)
3.3 United States Interventional Oncology Device Price by Type (2011-2016)
3.4 United States Interventional Oncology Device Sales Growth Rate by Type (2011-2016)

4 United States Interventional Oncology Device Sales (Volume) by Application (2011-2016)
4.1 United States Interventional Oncology Device Sales and Market Share by Application (2011-2016)
4.2 United States Interventional Oncology Device Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 United States Interventional Oncology Device Manufacturers Profiles/Analysis
5.1 Philips Volcano
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Interventional Oncology Device Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Philips Volcano Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Boston Scientific
5.2.2 Interventional Oncology Device Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Boston Scientific Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 GE Healthcare
5.3.2 Interventional Oncology Device Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 GE Healthcare Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Silicon Valley Medical Instruments
5.4.2 Interventional Oncology Device Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Silicon Valley Medical Instruments Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 St. Jude Medical
5.5.2 Interventional Oncology Device Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 St. Jude Medical Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Medtronic
5.6.2 Interventional Oncology Device Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Medtronic Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Hitachi Aloka Medical America
5.7.2 Interventional Oncology Device Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Hitachi Aloka Medical America Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Infraredx
5.8.2 Interventional Oncology Device Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Infraredx Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview

6 Interventional Oncology Device Manufacturing Cost Analysis
6.1 Interventional Oncology Device Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Interventional Oncology Device

7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Interventional Oncology Device Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Interventional Oncology Device Major Manufacturers in 2015
7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List

9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 United States Interventional Oncology Device Market Forecast (2016-2021)
10.1 United States Interventional Oncology Device Sales, Revenue Forecast (2016-2021)
10.2 United States Interventional Oncology Device Sales Forecast by Type (2016-2021)
10.3 United States Interventional Oncology Device Sales Forecast by Application (2016-2021)
10.4 Interventional Oncology Device Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix
Disclosure Section
Research Methodology
Data Source
Disclaimer

Figure Picture of Interventional Oncology Device
Table Classification of Interventional Oncology Device
Figure United States Sales Market Share of Interventional Oncology Device by Type in 2015
Table Application of Interventional Oncology Device
Figure United States Sales Market Share of Interventional Oncology Device by Application in 2015
Figure United States Interventional Oncology Device Sales and Growth Rate (2011-2021)
Figure United States Interventional Oncology Device Revenue and Growth Rate (2011-2021)
Table United States Interventional Oncology Device Sales of Key Manufacturers (2015 and 2016)
Table United States Interventional Oncology Device Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Interventional Oncology Device Sales Share by Manufacturers
Figure 2016 Interventional Oncology Device Sales Share by Manufacturers
Table United States Interventional Oncology Device Revenue by Manufacturers (2015 and 2016)
Table United States Interventional Oncology Device Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Interventional Oncology Device Revenue Share by Manufacturers
Table 2016 United States Interventional Oncology Device Revenue Share by Manufacturers
Table United States Market Interventional Oncology Device Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Interventional Oncology Device Average Price of Key Manufacturers in 2015
Figure Interventional Oncology Device Market Share of Top 3 Manufacturers
Figure Interventional Oncology Device Market Share of Top 5 Manufacturers
Table United States Interventional Oncology Device Sales by Type (2011-2016)
Table United States Interventional Oncology Device Sales Share by Type (2011-2016)
Figure United States Interventional Oncology Device Sales Market Share by Type in 2015
Table United States Interventional Oncology Device Revenue and Market Share by Type (2011-2016)
Table United States Interventional Oncology Device Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Interventional Oncology Device by Type (2011-2016)
Table United States Interventional Oncology Device Price by Type (2011-2016)
Figure United States Interventional Oncology Device Sales Growth Rate by Type (2011-2016)
Table United States Interventional Oncology Device Sales by Application (2011-2016)
Table United States Interventional Oncology Device Sales Market Share by Application (2011-2016)
Figure United States Interventional Oncology Device Sales Market Share by Application in 2015
Table United States Interventional Oncology Device Sales Growth Rate by Application (2011-2016)
Figure United States Interventional Oncology Device Sales Growth Rate by Application (2011-2016)
Table Philips Volcano Basic Information List
Table Philips Volcano Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Philips Volcano Interventional Oncology Device Sales Market Share (2011-2016)
Table Boston Scientific Basic Information List
Table Boston Scientific Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boston Scientific Interventional Oncology Device Sales Market Share (2011-2016)
Table GE Healthcare Basic Information List
Table GE Healthcare Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2011-2016)
Table GE Healthcare Interventional Oncology Device Sales Market Share (2011-2016)
Table Silicon Valley Medical Instruments Basic Information List
Table Silicon Valley Medical Instruments Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2011-2016)
Table Silicon Valley Medical Instruments Interventional Oncology Device Sales Market Share (2011-2016)
Table St. Jude Medical Basic Information List
Table St. Jude Medical Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2011-2016)
Table St. Jude Medical Interventional Oncology Device Sales Market Share (2011-2016)
Table Medtronic Basic Information List
Table Medtronic Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2011-2016)
Table Medtronic Interventional Oncology Device Sales Market Share (2011-2016)
Table Hitachi Aloka Medical America Basic Information List
Table Hitachi Aloka Medical America Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hitachi Aloka Medical America Interventional Oncology Device Sales Market Share (2011-2016)
Table Infraredx Basic Information List
Table Infraredx Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2011-2016)
Table Infraredx Interventional Oncology Device Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Interventional Oncology Device
Figure Manufacturing Process Analysis of Interventional Oncology Device
Figure Interventional Oncology Device Industrial Chain Analysis
Table Raw Materials Sources of Interventional Oncology Device Major Manufacturers in 2015
Table Major Buyers of Interventional Oncology Device
Table Distributors/Traders List
Figure United States Interventional Oncology Device Production and Growth Rate Forecast (2016-2021)
Figure United States Interventional Oncology Device Revenue and Growth Rate Forecast (2016-2021)
Table United States Interventional Oncology Device Production Forecast by Type (2016-2021)
Table United States Interventional Oncology Device Consumption Forecast by Application (2016-2021)

Request a Sample Copy

  • * :
  • * :
  • * :
  • * :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top